GlassScriptPhysician profile
Scott L Brown
NPI 1477592681
$10,558.74
in general payments reported to CMS, 2019-2025
45 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $3,431 · 2021: $1,603 · 2022: $1,184 · 2023: $1,088 · 2024: $924 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,107 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,107.09 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,446.87 | 2020 | |
| Abbvie INC. | $899.89 | 2019-2025 | Lupron Depot |
| Astellas Pharma US INC | $826.95 | 2019-2024 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $809.20 | 2019-2025 | |
| Coloplast Corp | $637.01 | 2019-2025 | Speedicath |
| Janssen Biotech, INC. | $528.20 | 2021-2025 | Erleada |
| Urogen Pharma, INC. | $318.34 | 2020-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $291.63 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $285.10 | 2021-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $264.95 | 2020-2024 | Prolaris |
| Myovant Sciences INC. | $228.37 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $211.23 | 2021-2025 | |
| Pfizer INC. | $210.56 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $195.02 | 2019-2024 | Provenge |
| Sumitomo Pharma America, INC. | $194.54 | 2023-2025 | Gemtesa, Orgovyx |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $183.07 | 2024-2025 | |
| Tolmar Pharmaceuticals, INC. | $182.11 | 2019-2022 | |
| Boston Scientific Corporation | $174.07 | 2019-2024 | Rezum Generator |
| Accord Healthcare, INC. | $162.63 | 2024-2025 | |
| 180 Medical, INC. | $152.74 | 2019-2025 | Gentlecath Glide, Cure Catheter |
| Allergan, INC. | $125.95 | 2019-2021 | |
| Procept Biorobotics Corporation | $117.82 | 2021-2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $95.58 | 2019-2025 | Adstiladrin |
| Teleflex LLC | $95.13 | 2022-2023 | Urolift |
| Biotissue Holdings INC. | $84.34 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $79.19 | 2019 | |
| Merck Sharp & Dohme LLC | $67.74 | 2020-2021 | |
| Tolmar, INC. | $66.02 | 2023 | |
| Convatec INC. | $65.26 | 2019-2023 | |
| Telix Pharmaceuticals | $59.62 | 2022-2025 | Illuccix |
| Verity Pharmaceuticals INC. | $49.18 | 2025 | Trelstar |
| Zyla Life Sciences, INC. | $43.87 | 2019-2020 | |
| Olympus America INC. | $43.05 | 2024-2025 | Itind System |
| Blue Earth Diagnostics | $43.05 | 2019-2020 | |
| Axonics, INC. | $41.87 | 2022-2023 | Axonics |
| Abc Home Medical Supply, INC. | $41.86 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $41.02 | 2023 | |
| Hollister Incorporated | $38.33 | 2021 | |
| Alnylam Pharmaceuticals INC. | $27.90 | 2021 | |
| Dentsply Ih INC. | $24.81 | 2019 | |
| Neotract INC. | $24.29 | 2020 | |
| Foundation Medicine, INC. | $23.67 | 2023 | |
| Sagent Pharmaceuticals | $21.57 | 2023 | Glydo |
| Travere Therapeutics, INC. | $20.43 | 2019 | |
| Photocure INC | $14.71 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.